Healthcare and Life Science
What drives us: Rethinking motivation, engagement and mental health
Why do we only talk about motivation when we don't have any? We need to start talking about motivation regularly - our cars don't run with empty fuel tanks, and neither do we. Our motivation has a huge impact on performance, engagement and wellbeing, and I am on a mission to change th...
From Concept to Commercialisation: How The EpiCentre Powers Biotech Growth
Biotech innovation rarely follows a straight line. The journey from initial concept to commercialised product is one marked by technical complexity, regulatory hurdles, and the constant challenge of scaling a viable innovative business. But one thing is certain: where you choose to buil...
Atelerix and Rodon Global partner to integrate cryo-free preservation technology into specialist logistics solutions
Initial agreement to incorporate Atelerix’s non-cryogenic cell preservation technology into international freight and logistics services for drug discovery and clinical trialsPartnership showcased at SACRA (South African Clinical Research Association), Pretoria, 1–2 October 2025Newcastl...
CN Bio adds computational modeling capabilities to ADME services for enhanced bioavailability profiling
New PhysioMimix in silico tools unlock deeper functional insights from existing assays, advancing translation of MPS data to predict human ADME behaviorEnd-to-end support from experimental design to data interpretationCambridge, UK, 02 September 2025: CN Bio, a leading provider of Organ...
TRIMTECH Therapeutics establishes Scientific Advisory Board
Targeted protein degradation experts Prof.
Guardtech Group set for exciting awards treble to close out buoyant performance in 2025
The East Anglian cleanroom construction specialists are up for prizes at the Pharma Industry Awards, London Construction Awards and SME National Business Awards grand finals ...
Qureight appoints Craig Rhodes as Head of Partnerships to lead on pharma relationship management
Appointment underscores Qureight’s commitment to drive adoption of its AI-powered imaging and clinical data curation platform to support clinical trials and accelerate drug development timelines for lung and heart diseasesFormer big tech executive and NVIDIA director with proven track r...
Award-winning OrganOx acquired by global MedTech company for $1.5Bn
OrganOx, a University of Oxford spin-out, has been acquired by global MedTech company, Terumo, for $1.5 billion. This comes after OrganOx recently won the prestigious Royal Academy of Engineering MacRobert Award for its pioneering devices that keep donor livers and kidneys alive outside...
Qureight’s AI 3D imaging platform to support Calluna Pharma’s Phase 2 AURORA study of CAL101 in Idiopathic Pulmonary Fibrosis (IPF)
Qureight’s advanced AI 3D imaging platform to be used across clinical trial to evaluate anatomical lung changes in adult patients, including during patient enrolmentCAL101 is a first-in-class monoclonal antibody that neutralises the S100A4 protein, which is an upstream driver and amplif...